Fortrea’s non-commercial specialty pharmacy expansion delivers flexible, scalable solutions to customers and life-changing medications direct to patients DURHAM, N.C., Feb. 20, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced the opening of its expanded non-commercial specialty pharmacy, FortreaRx™, located in

Fortrea’s non-commercial specialty pharmacy expansion delivers flexible, scalable solutions to customers and life-changing medications direct to patients DURHAM, N.C., Feb. 20, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced the opening of its expanded non-commercial specialty pharmacy, FortreaRx™, located in

Axi Select SYDNEY, Australia, Feb. 20, 2024 (GLOBE NEWSWIRE) — Bucking the trend of recent negative developments in the prop firm industry, leading global CFD and FX broker Axi, which launched Axi Select – their unique capital allocation programme for talented traders – has been hailed by many industry experts

Axi Select SYDNEY, Australia, Feb. 20, 2024 (GLOBE NEWSWIRE) — Bucking the trend of recent negative developments in the prop firm industry, leading global CFD and FX broker Axi, which launched Axi Select – their unique capital allocation programme for talented traders – has been hailed by many industry experts